NCT04814108 2026-03-18
A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2 Completed
Clinical Trials
5 trialsNCT02101788 2025-11-13
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT04458597 2025-08-01
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT00551070 2020-12-03
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00515073 2014-07-03
Papillary Serous Carcinoma of the Endometrium
M.D. Anderson Cancer Center
Phase 2 Completed